Evidence map›Paper›PMID 40443838›Full record

ArticleCureus2025

Concurrent Diagnosis and Management of Primary Mediastinal Germ Cell Tumor and Klinefelter Syndrome.

David D Kim, Juan M Alcantar, Fukai L Chuang

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David D KimHematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Juan M AlcantarHematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Fukai L ChuangHematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary mediastinal nonseminomatous germ cell tumor (PMNSGCT) stands out among other germ cell tumors not only because of its mediastinal site of origin, but by its aggressive behavior, need for maximal multidisciplinary therapy, and relatively poor prognosis. We present a case of a 22-year-old man who was evaluated for chest-related and systemic symptoms and found to have a large mediastinal mass compressing the pulmonary artery with no apparent disease outside the mediastinum. Physical exam at presentation to medical oncology revealed gynecomastia and small testicles, suspicious for sex hormone dysregulation. Workup revealed the diagnosis of PMNSGCT as well as Klinefelter syndrome (KS), a sex chromosome abnormality condition in males caused by an extra copy of the X chromosome. The association between these two conditions is reported but not well known, given the uncommon incidence of both and the lack of an obvious connection. Pre-treatment management included referral to multidisciplinary specialties and assessment for fertility preservation. The patient was treated with a curative intent with etoposide, ifosfamide, and cisplatin (VIP) chemotherapy for four cycles at full doses despite various side effects. He underwent surgical resection of his residual mediastinal mass, with pathology revealing a complete pathologic response, which is considered a good prognostic indicator for survival. Therefore, he did not require adjuvant chemotherapy. He was started on testosterone replacement therapy for KS-related hypogonadism with improvement in his testosterone level and quality of life. To date, he has not had evidence of recurrence. We discuss the evaluation and management of PMNSGCT and KS, as well as the evidence for their association reported in the literature.

Indexed as

germ cell tumorhypogonadismklinefelter syndromemediastinal massprimary mediastinal germ cell tumortestosterone replacement therapyvip chemotherapy

Identifiers

PMID40443838
PMCPMC12119978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.